Local Cdiff information for South Carolina
South Carolina
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in South Carolina.
Local Cdiff information for South Carolina
South Carolina
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in South Carolina.
Providers
Scott Curry, MD
Emilio V. Perez-Jorge, MD, FACP
Lexington Medical Park 2
146 East Hospital Drive
Suite 120A
West Columbia, SC 29169
Phone: (803) 936-7460
Regulation
C. diff Infections
Total Reported Cases: 1255
Hospital Onset: 1255
Community Onset: Not reported
Related Deaths: Not reported
Available Reports
State Reporting Laws
Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: Yes
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: South Carolina Law
State Contact
Kate Habicht, MPH
Healthcare-associated Infections Epidemiologist
South Carolina Department of Health and Environmental Control
Division of Acute Disease Epidemiology
2100 Bull St.
Columbia, 29201
(803) 898-0575
(803) 898-0897
CLINICAL TRIALS
ROAR
Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older
RESTORATiVE303
Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.
C.Difficile Observational Study
Official Title: An Observational Study in Adults With Clostridioides Difficile Infection to Determine the Feasibility and Logistics of Biospecimen Collection, Transportation and Testing at Select US Study Sites
Trial No. NCT06277999
Type: Observational
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
Trial No. NCT06277999
Type: Observational
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
Gender: All
Age: 18 Years and older